Related references
Note: Only part of the references are listed.RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression
Manuel Sanclemente et al.
CANCER CELL (2021)
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
Ivana Yen et al.
NATURE (2021)
The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin et al.
CANCER DISCOVERY (2020)
Sticking it to KRAS: Covalent Inhibitors Enter the Clinic
Frank McCormick
CANCER CELL (2020)
PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network
Kurt M. Reichermeier et al.
MOLECULAR CELL (2020)
RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
Irem Ozkan-Dagliyan et al.
CELL REPORTS (2020)
Progress in targeting RAS with small molecule drugs
Frank McCormick
BIOCHEMICAL JOURNAL (2019)
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes
Eunyoung Park et al.
NATURE (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling
Elizabeth M. Terrell et al.
MOLECULAR CELL (2019)
c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling
Manuel Sanclemente et al.
CANCER CELL (2018)
Kinase domain dimerization drives RIPK3-dependent necroptosis
Saravanan Raju et al.
SCIENCE SIGNALING (2018)
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
Ivana Yen et al.
CANCER CELL (2018)
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
Arun M. Unni et al.
ELIFE (2018)
A Braf kinase-inactive mutant induces lung adenocarcinoma
Patricia Nieto et al.
NATURE (2017)
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα
Andrea Varga et al.
SCIENCE SIGNALING (2017)
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα
Andrea Varga et al.
SCIENCE SIGNALING (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Negative feedback regulation of the ERK1/2 MAPK pathway
David Lake et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
Channing Yu et al.
NATURE BIOTECHNOLOGY (2016)
The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs)
Andrew M. Kidger et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions
Saori Fujita-Sato et al.
CANCER RESEARCH (2015)
Alike but Different: RAF Paralogs and Their Signaling Outputs
Enrico Desideri et al.
CELL (2015)
Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors
Steven R. Whittaker et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Regulation of RAF protein kinases in ERK signalling
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
Sunil J. Advani et al.
NATURE COMMUNICATIONS (2015)
A comprehensive transcriptional portrait of human cancer cell lines
Christiaan Klijn et al.
NATURE BIOTECHNOLOGY (2015)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Identification of Mutant K-Ras-dependent Phenotypes Using a Panel of Isogenic Cell Lines
Steffan Vartanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
Georgia Hatzivassiliou et al.
NATURE (2013)
Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition
Klaus P. Hoeflich et al.
CANCER RESEARCH (2012)
Increased BRAF Heterodimerization Is the Common Pathogenic Mechanism for Noonan Syndrome-Associated RAF1 Mutants
Xue Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma
Rafael B. Blasco et al.
CANCER CELL (2011)
C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D
Florian A. Karreth et al.
CANCER DISCOVERY (2011)
Impact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
Daniel A. Ritt et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Essential role of B-Raf in ERK activation during extraembryonic development
G Galabova-Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes
Julie M. Pratt et al.
NATURE PROTOCOLS (2006)
Raf-1 regulates Rho signaling and cell migration
K Ehrenreiter et al.
JOURNAL OF CELL BIOLOGY (2005)
Regulation of raf-1 by direct feedback phosphorylation
MK Dougherty et al.
MOLECULAR CELL (2005)
Rote of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1
E O'Neill et al.
SCIENCE (2004)
Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf
T Brummer et al.
ONCOGENE (2003)
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway
H Hanafusa et al.
NATURE CELL BIOLOGY (2002)
ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf
K Mercer et al.
ONCOGENE (2002)
MEK kinase activity is not necessary for Raf-1 function
M Hüser et al.
EMBO JOURNAL (2001)
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene
M Mikula et al.
EMBO JOURNAL (2001)
Share Paper
